(2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide

C29H32N6O4 — CID 25309067

IUPAC(2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide
SMILESCOc1ccc(N(C(=O)Cn2nnc(-c3ccccc3)n2)[C@H](C(=O)NC2CCCCC2)c2ccc(C)o2)cc1
InChIInChI=1S/C29H32N6O4/c1-20-13-18-25(39-20)27(29(37)30-22-11-7-4-8-12-22)35(23-14-16-24(38-2)17-15-23)26(36)19-34-32-28(31-33-34)21-9-5-3-6-10-21/h3,5-6,9-10,13-18,22,27H,4,7-8,11-12,19H2,1-2H3,(H,30,37)/t27-/m0/s1
InChIKeyDCHGBHSNDAWRJS-MHZLTWQESA-N
MW528.61 g/mol
LogP4.47
Rot. Bonds9

About (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide

(2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide (PubChem CID 25309067) has the molecular formula C29H32N6O4 and a molecular weight of 528.61 g/mol. Its IUPAC name is (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide.

Molecular Properties

Compound Name(2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide
PubChem CID25309067
Molecular FormulaC29H32N6O4
Molecular Weight528.61 g/mol
Exact Mass528.25
IUPAC Name(2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide
SMILESCOc1ccc(N(C(=O)Cn2nnc(-c3ccccc3)n2)[C@H](C(=O)NC2CCCCC2)c2ccc(C)o2)cc1
InChIInChI=1S/C29H32N6O4/c1-20-13-18-25(39-20)27(29(37)30-22-11-7-4-8-12-22)35(23-14-16-24(38-2)17-15-23)26(36)19-34-32-28(31-33-34)21-9-5-3-6-10-21/h3,5-6,9-10,13-18,22,27H,4,7-8,11-12,19H2,1-2H3,(H,30,37)/t27-/m0/s1
InChIKeyDCHGBHSNDAWRJS-MHZLTWQESA-N
XLogP4.47
TPSA115.38 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500528.61
LogP ≤ 54.47
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide?
The IUPAC name of (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide (CID 25309067) is (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide.
What is the SMILES notation for (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide?
The canonical SMILES for (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide is COc1ccc(N(C(=O)Cn2nnc(-c3ccccc3)n2)[C@H](C(=O)NC2CCCCC2)c2ccc(C)o2)cc1.
What is the InChIKey of (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide?
The InChIKey is DCHGBHSNDAWRJS-MHZLTWQESA-N. The full InChI is InChI=1S/C29H32N6O4/c1-20-13-18-25(39-20)27(29(37)30-22-11-7-4-8-12-22)35(23-14-16-24(38-2)17-15-23)26(36)19-34-32-28(31-33-34)21-9-5-3-6-10-21/h3,5-6,9-10,13-18,22,27H,4,7-8,11-12,19H2,1-2H3,(H,30,37)/t27-/m0/s1.
What are the key properties of (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide?
(2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide has a molecular weight of 528.61 g/mol, XLogP of 4.47, 9 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-cyclohexyl-2-(4-methoxy-N-[2-(5-phenyltetrazol-2-yl)acetyl]anilino)-2-(5-methylfuran-2-yl)acetamide is sourced from PubChem (CID 25309067), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).